(NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ophthalmic technology company focused on completing development of its proprietary Optejet topical ophthalmic medication dispensing platform, today ...

The company has already cut its workforce, seen a leadership change and agreed to be acquired. Here's what's next.

Eyenovia, Inc. (NASDAQ: EYEN) ("Eyenovia" or the "Company"), an ophthalmic technology company focused on completing development of its proprietary Optejet ...

Enveric Biosciences Inc. (NASDAQ:ENVB), a pharmaceutical preparations company with a market capitalization of $3.43 million, ...

REVB READ THE FULL REVB RESEARCH REPORT Revelation Biosciences (NASDAQ:REVB) announced that it has initiated its US based Phase 1b clinical study to evaluate the potential of Gemini as a ...

Each compensation amount is treated separately, and the various different components of the compensation need to be split up into their component ... if they had received appropriate advice. The tax ...

It’s shaping up as a big year for late-stage Australian-listed drug developers, with analysts tipping potentially hefty share ...

Advanced Micro Devices (AMD -6.37%) has been a top performer in the semiconductor industry over the last decade. The fabless chip stock has grabbed market share from Intel PCs and ...

The Company's Board of Directors approved the reverse stock split at a ratio of 1-for-150 shares on January 25, 2025, following approval for the action by Crown's stockholders at a special ...

ZK International Group (ZKIN) announces 1-for-7 reverse stock split to meet NASDAQ listing requirements, effective Jan.